Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Large & Mid Cap Fund median (36 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 03 Apr 2006 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty Midcap 150 history starts 14 Jan 2019, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | UTI Large & Mid Cap Fund |
|---|---|
| 03 Apr 2006 | ₹100.00 |
| 14 Dec 2007 | ₹166.02 |
| 26 Aug 2009 | ₹58.60 |
| 08 May 2011 | ₹68.94 |
| 17 Jan 2013 | ₹77.17 |
| 30 Sep 2014 | ₹107.48 |
| 11 Jun 2016 | ₹118.65 |
| 21 Feb 2018 | ₹155.29 |
| 04 Nov 2019 | ₹148.58 |
| 16 Jul 2021 | ₹228.07 |
| 28 Mar 2023 | ₹237.02 |
| 08 Dec 2024 | ₹443.23 |
| 20 Aug 2026 | ₹459.64 |
| Metric | UTI · Regular NAV ₹187.63 Very High risk ★★★☆☆ | Category median Large & Mid Cap Fund · 36 funds |
|---|---|---|
| +4.47% | +5.52% | |
| +16.46% | +14.91% | |
| +15.04% | +13.37% | |
| +13.72% | +14.19% | |
| +7.77% | +12.93% | |
| +14.74% | — | |
| +8.95% | +14.91% | |
| +9.51% | +14.70% | |
| +9.63% | +13.49% | |
| Risk | ||
| 13.70% | 14.80% | |
| 0.73 | 0.54 | |
| 0.99 | 0.73 | |
| -70.11% | -37.25% | |
| Nifty Midcap 150 | — | |
| +0.90% | -0.76% | |
| 0.80 | 0.83 | |
| 81.5% | 81.1% | |
| 70.0% | 81.1% | |
| 1.95% | 2.37% | |
| ₹6,407Cr | ₹3,576Cr | |
| 1.00% | — | |
| None | — | |
| ₹500 | — | |
| ₹5.00K | — | |
| 60% | 42% | |
| V Srivatsa · 9.3y | — | |
| 03 Apr 2006 | — | |
| 69 | — | |
| 32.6% | — | |
| 2.2% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.